PharmaBoardroom

COVID-19 / Lessons from MSD’s Ebola Vaccine Development:…

While outbreaks of the devastating Ebola virus have – thankfully – generally been highly localized to West Africa, the highly infectious and…

China: The Pharma Deals Keep Coming

The latest from Chinese pharma, with dealmaking continuing apace. Featured this week are Zai Lab’s latest IPO listing in Hong Kong, InventisBio…

Market Access in Switzerland: Reimbursement Delays for 76% of New…

Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if innovative new medicines continue to…

US Elections: Biden & Trump’s Unworkable Drug Pricing…

In the aftermath of the fiery first presidential debate between incumbent Donald Trump and Democratic Party rival Joe Biden, we round up the latest on…

Stephan Mumenthaler – Director General, scienceindustries,…

scienceindustries’ Stephan Mumenthaler outlines the business-friendly regulation necessary to maintain Swiss life sciences’ competitive edge, how…

Peter Marks – Director, Center for Biologics Evaluation and…

Dr Peter Marks MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), highlights…

Ole Olesen – Executive Director, European Vaccine…

Ole Olesen, executive director of the European Vaccine Initiative (EVI), shares the highlights of his first nine months in the job grappling with a…

This Could Get Messy: Trump’s New ‘Most Favoured Nation’…

Regular PharmaBoardroom contributor Brendan Shaw weighs in on the potential implications for US pharma of President Donald Trump’s latest executive…

Biosimilar Adoption in the US: Still Lagging Behind Europe

As part of our upcoming US Healthcare and Life Sciences Review, we spoke to key stakeholders – former Association for Accessible Medicines (AAM)…

Gilead’s Remdesivir: No Overnight Success Story

With remdesivir practically a household name today as the first therapeutic to be approved for the treatment of COVID-19 patients, Gilead chairman and…

Norway: Staking a Claim as a Pharma Research Hub

Norway, more well-known internationally as an innovation hub for oil & gas and marine biology, is attempting to reverse the trend of reducing…

Switzerland Innovation & Competitiveness Snapshot 2020

In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The country is also losing ground in…

Tagged with US